We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05494762
Brief Title: Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

First Submitted : August 8, 2022
First Submitted that Met QC Criteria : August 8, 2022
First Posted : August 10, 2022

Last Update Submitted that Met QC Criteria : November 17, 2022
Last Update Posted : November 21, 2022